
Targeted research audiences with AI-verified data quality
Targeted research audiences with AI-verified data quality
Delve AI records 49,025 monthly visits with -4.6% month-over-month growth and Freemium pricing. Unlearn.AI records 17,107 monthly visits with -32.5% growth and Contact for Pricing pricing.

AI-generated digital twins that make clinical trials smaller, faster, and more informative
| Dimension / Metric | ![]() | |
|---|---|---|
| Official Domain | delve.ai | unlearn.ai |
| Pricing Model | Freemium | Contact for Pricing |
| Monthly Visits | 49.03K (49,025) | 17.11K (17,107) |
| MoM Traffic Delta | -2.35K (-4.6%) | -8.23K (-32.5%) |
| Primary Market & Share | 🇺🇸 United States (10.9%) | 🇺🇸 United States (69.4%) |
| Direct Visits / mo | 19.72K | 7.49K |
| User Rating | 4.3 | 4.4 |
| Supported Platforms | Website | Website |
Generate data-backed personas, digital twins and synthetic research on demand
Build comprehensive customer, user, audience and employee personas from first-party and public data, with automatic segmentation and in-depth audience insights.
Turn personas into interactive twins you can chat with 24/7 to test ideas, ask questions and make customer-centric decisions without scheduling interviews.
Run surveys, interviews, focus groups and UX tests against AI personas of your audience to get scalable, cost-effective results in minutes.
Receive channel-specific marketing and campaign recommendations derived from persona insights, with dynamic updates as your data evolves.

AI-generated digital twins that make clinical trials smaller, faster, and more informative
Model-based forecasts of each participant's clinical outcomes, generated from baseline data already collected, that act as a virtual comparator or as additional information per enrolled patient.
A twin-based covariate adjustment approach that Unlearn describes as EMA-qualified and FDA-supported, used to reduce sample size in randomized controlled trials while maintaining power.
Build and compare design scenarios — endpoints, eligibility criteria, sample size, assumptions — so governance decisions are made with quantified tradeoffs instead of positions.
Pre-specified twin-based analyses added to the statistical analysis plan before unblinding, plus twin-adjusted analysis delivered at interim and at readout.

Targeted research audiences with AI-verified data quality
Targeted research audiences with AI-verified data quality

AI-moderated customer interviews that turn conversations into decisions
AI-moderated customer interviews that turn conversations into decisions
Free / Open-sourceGuideline-directed medical answers with citations, built for clinicians
Free / Open-sourceGuideline-directed medical answers with citations, built for clinicians
Free / Open-sourceAI therapy notes and an AI-native EHR built for mental health professionals.
Free / Open-sourceAI therapy notes and an AI-native EHR built for mental health professionals.

Verified B2B and healthcare respondents for high-quality research

AI-native customer intelligence platform that turns every customer conversation into context
AI-native customer intelligence platform that turns every customer conversation into context

AI lung cancer screening that finds eligible patients and scores every nodule
AI lung cancer screening that finds eligible patients and scores every nodule

Agile MROps platform that unifies market research with AI, automation, and data quality controls
Agile MROps platform that unifies market research with AI, automation, and data quality controls

AI user research platform that runs synthetic interviews and delivers a report in 30 minutes
AI user research platform that runs synthetic interviews and delivers a report in 30 minutes
Run surveys, AI interviews, and usability tests in one research workspace
Run surveys, AI interviews, and usability tests in one research workspace

Enterprise clinical AI that turns medical imaging into faster, more confident care decisions.
Enterprise clinical AI that turns medical imaging into faster, more confident care decisions.

Engineer better proteins, faster, with AI